US 9592304
Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors
granted A61KA61K38/00A61K47/6849
Quick answer
US patent 9592304 (Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Mar 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61K, A61K38/00, A61K47/6849, A61P, A61P35/00